Latest Breaking News On - Its indicationsalectinib - Page 1 : comparemela.com

Alectinib approved by US FDA for auxiliary treatment of patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) who underwent tumor resection.

United kingdomIsrael ministry of healthAustralian therapeutic goods administrationGenentech incDrug administration onRegulatory agencyOncology centerHealth canadaDrug administrationIts indicationsalectinibClinical trialResults theEffects noted duringTrial alectinibProject orbisLung cancer